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Nanoporous silica coatings on implant surfaces: 
characterization, stability, biocompatibility and 
drug release properties
Abstract: Nanoporous silica coatings for drug release pur-
poses were prepared on medical implants. As substrate, 
we chose Bioverit® II, which is a commercial available 
glass-mica ceramic implant material. The coating was 
prepared by a dip-coating technique in which long-chain 
organic molecules act as placeholders for the pores. 
Characterization of the coatings by scanning transmis-
sion electron microscopy and X-ray diffraction showed 
a disordered nanoporous system with a layer thickness 
of 30–150 nm. The nanoporous structure was stable for 
about 12 h in a typical cell culture medium and rearranged 
to a packing of silica nanoparticles. The coating allowed 
cell attachment and showed excellent biocompatibility in 
cell culture tests independently of the particular cell type 
examined. In vivo, implant-tissue interactions were exam-
ined in the middle ear in a novel mouse model. Whole 
genome expression profiling showed no persisting inflam-
matory response in the presence of the implants. Release 
profiles of the antibiotic ciprofloxacin demonstrated that 
the coating is suitable for a local drug delivery. The drug 
loading capacity could be drastically increased after sul-
fonic acid modification of the Bioverit® II surface.
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Introduction
Glass-ceramic materials are known to have a very good 
tissue compatibility [1–3]. Typical applications are in 
non-load bearing areas such as head and neck surgery, 
bone substitution after cancer treatment, and in ossic-
ular chain reconstruction surgery [4]. Bioverit® II is an 
advanced glass-mica ceramic implant material that is 
highly biocompatible, insoluble and corrosion-resistant 
and possesses excellent machining properties [5]. Fur-
thermore, Bioverit® II is clinically well established mainly 
as a bone replacement material in skull and middle ear 
reconstructive surgery [6–9]. Nevertheless, no pres-
ently available material is optimally suited to fulfill the 
diverse requirements of all possible applications. As an 
alternative to the search for entirely novel materials, an 
attractive option is the coating of clinically established 
implant materials to add specific functions to influence 
the implant-issue interaction. In particular, porous coat-
ings can serve as drug reservoirs.
Besides the coating material itself various surface 
structures can influence the biological properties of an 
implant [10]. As an example for nanostructured materi-
als, nanoporous silica materials [11, 12] have been pro-
posed for applications in bone reconstruction [13, 14]. 
Nanoporous materials with pores in the range from 2 
to 15  nm can be prepared by silica sol-gel processes. In 
the general materials chemi stry literature, these materi-
als are usually designated as ‘mesoporous’; however, 
in the biological context of these investigations we 
prefer the term ‘nanoporous’. Normally, these materials 
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are produced by solution-phase synthesis in form of a 
powder or as nanoparticles [15], but it is difficult to envis-
age how these can be applied with a pre-formed implant 
or prosthesis. Further developments showed that nano-
porous silica materials can be produced as thin films on 
various substrates [16, 17] and that these films are suit-
able for drug release applications [18]. For these reasons, 
we focused on establishing a nanoporous silica film on 
a ceramic or glass-ceramic surface. The main features of 
nanoporous silica coatings are their excellent biocompat-
ibility, the increased exposed surface area with respect to 
dense coatings, the corresponding increase in functional 
silanol (Si-OH) surface groups available for chemical 
modification, and the interior pore space, which could be 
used as a depot for local drug delivery.
With regard to that option and the numerous pro-
blems with postoperative implant-associated infections 
in implant surgery, a nanoporous silica coating with the 
 possibility for a controlled drug release was deve loped 
[19]. Infections in implant surgery are caused by bacteria 
which are already present in the patient, or which are 
introduced to the implantation site during the opera-
tion [20]. However, these infections can spread from the 
implantation area and may thus necessitate a further 
treatment with antibiotics. Normally, such treatments 
are applied systemically, which is stressful for the body 
and can cause harmful side effects as well as the for-
mation of a bacterial resistance. Additionally, it is pos-
sible that a systemic treatment of the infections may 
be insufficient in case of the formation of a biofilm on 
the implant surface [21]. Therefore, it would be useful 
to equip the prosthesis with a reservoir of antibiotics 
in order to fight the infection with a sufficient dose at 
the point of infection and suppress the formation of a 
biofilm on the implant. In the special case of middle ear 
prostheses, often chronic infections are occurring. Here, 
it would be a great advantage to immediately fight bac-
teria and support in that way the healing process after 
implantation.
Here, we report about the preparation and a compre-
hensive in vitro and in vivo evaluation of a nanoporous 
silica coating on a medical implant material. We chose 
the glass mica-ceramic Bioverit® II as base material for 
the coating, as it is a commercially available implant 
material for a variety of applications, and is for example 
often used for the functional replacement of the middle 
ear ossicular chain. In preliminary in vitro investigations 
and for thorough characterization, standard glass slides 
were used as substrates. A reliable coating procedure 
was developed and the structure and morphology of the 
coatings were determined. The nanoporous coating was 
investigated by, scanning transmission electron micros-
copy (STEM) and X-ray diffraction (XRD). The coating was 
tested with regard to its stability in physiological medium 
and the properties of the nanoporous silica coating based 
drug release system were determined. Furthermore, the 
interactions of the coating with cultured cells and even-
tually with relevant tissues in animal models were evalu-
ated in molecular detail. The release of ciprofloxacin was 
studied from Bioverit® II platelets coated with nanopo-
rous silica. Ciprofloxacin is an antibiotic which is used to 
treat middle ear infections caused by Pseudomonas aer-
uginosa, a pathogen typical for such infections.
Results and discussion
 Preparation of nanoporous silica coatings
Nanostructured silica films were selected as a biocompat-
ible coating material. When tetraethoxysilane is hydro-
lyzed in an aqueous medium, monosilicic acid forms an 
amorphous silica network upon evaporation of the liquid 
phase. In an approach designated as structure-directed 
synthesis, amphiphilic molecules can be used to influ-
ence the structure formation of amorphous silica [22–24]. 
The organic amphiphilic molecules can form micelles 
with cylindrical or spherical shape and lyotropic liquid 
crystal phases. The silica network formation has been 
proposed to take place around the micellar aggregates of 
the amphiphilic molecules, resulting in an as-synthesized 
organic-inorganic hybrid nanostructured solid phase 
[25]. Removal of the organic placeholder molecules from 
the as-synthesized coating by oxidation has been demon-
strated to yield nanoporous silica with typical pore sizes 
between 2 and 10 nm. In order to coat implants with nan-
oporous silica, either dip-coating or spray-coating proce-
dures can be applied. The dip-coating procedure for the 
production of nanoporous silica films has been investi-
gated intensively and has been shown to follow the evap-
oration-induced self-assembly (EISA) mechanism [26]. In 
this work, glass slides and Bioverit® II samples were both 
coated by an established dip-coating procedure using the 
non-ionic amphiphilic compound EO20PO70EO20 [19, 27, 
28]. The coating was air-dried resulting in the as-synthe-
sized coating. On Bioverit® II  supports with their rough 
surface structure, the procedure was repeated twice to 
ensure complete coatings.  Subsequently, the silica was 
dried and the structure-directing molecules which have 
acted as organic  placeholders, were removed by calcina-
tions (heating in air at 415°C).
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X-ray diffraction
The characteristic repeat size of the nanostructured silica 
layers generates X-ray diffraction reflections at low 2θ 
values. The as-synthesized films show a reflection at 1.1° 2θ 
which is shifted to 1.6° 2θ for the calcined ones (Figure 1), 
reflecting regular structures of 8.0 nm and 5.5 nm repeat 
size, respectively. Furthermore, the nanoporous material 
exhibit a very broad reflection at 3° 2θ.
These dimensions are characteristic for the supra-
molecular arrangements of the organic placeholder mole-
cules added to the silica solution. Calcination reduced the 
dimensions of these structures to about 66% of the size 
of the as synthesized coatings. It is well established that 
the removal of the organic molecules by calcination from 
bulk amphiphile-templated nanostructured silica leads 
to a reduction of the dimension of the nanostructures due 
to increased silica condensation [11]. The singular reflec-
tions observed in the X-ray diffraction patterns are evoked 
by the electron density contrast between the silica wall 
Figure 1 The presence of amphiphilic polymeric molecules during 
the synthesis of silica coatings results in the generation of regular 
structures in the nanometer range which are reflected in the X-ray 
diffractograms of silica films on glass slides (bottom two lines) 
and on Bioverit® II substrates (top two lines; ns: as-synthesized 
(nano-structured) layers still containing the amphiphilic structure-
directing agent; np: nanoporous layers after removal of the 
amphiphilic structure-directing agent. The diffraction patterns show 
a broad major peak at 1.1° 2θ for the as-synthesized and 1.6° 2θ for 
the nanoporous material, reflecting regular structures of 8.0 nm 
and 5.5 nm repeat size, respectively. In the patterns of the Bioverit® 
II-based samples, the sharp peak at ca. 9° 2θ stems from the 
 crystalline parts of the glass-mica ceramic.
material and either the organic material or, after calcina-
tion, the empty pores. Their presence reflects a regular 
pore diameter and distance between pores. As apart from 
the broad reflections no other significant diffraction phe-
nomena can be observed at low 2θ values, the pores in 
the coatings we produced have no ordered arrangement, 
as described previously [19, 27, 28], as specific periodic 
pore packings (as  hexagonal, cubic or lamellar) would 
lead to additional reflections. The mesopore structure 
is thus disordered, similar to bulk nanoporous materi-
als of the LMU-1 [24] or KIT-1 [29] type. The fact that the 
same reflections can be found on the coated Bioverit® II 
samples shows that the nanostructure of the silica film 
is present on the ceramic substrate as well. Additionally, 
the Bioverit® II samples exhibit another reflection at 9° 2θ 
which is caused by the crystalline parts of the substrate 
material.
Overall, XRD results showed that disordered nano-
structured silica coatings with a characteristic repeat unit 
were reproducibly obtained by the dip-coating technique 
and EISA.
STEM studies
In accordance to the XRD results, electron microscope 
images revealed a disordered arrangement of the nanopo-
rous film (Figure 2).
The side-view of an intentionally broken layer shows 
the good attachment of the film on the glass substrate 
(Figure 2A). Having a closer look on the surface (Figure 2B), 
pore mouth openings can be seen on the surface and the 
pore system lying below can be accessed from them, an 
important requirement for drug release applications. In 
the cross section image (Figure 2C) of the coating, pore 
channels can be observed which run primarily parallel to 
the substrate, but otherwise in different directions. These 
channels appear to be interrupted at irregular intervals. 
Clearly, the pore system is not ordered. The predomi-
nantly parallel orientation of the pore channels is caused 
by the liquid flow during dip-coating. From Figure 2C, the 
thickness of the film can be determined to 40 nm. Further 
investigations showed that the thickness of one layer is 
between 30 and 150 nm and the inner surface area of the 
film is increased to 11.2 cm2 per cm2 of the substrate [19].
In Figure 3, an STEM cross-section micrograph of the 
nanoporous silica film on a Bioverit® II substrate can be 
seen. The irregular nanoporous structure of the film can 
be clearly recognized here as well, with a pore size similar 
as observed on films on glass slides. The porous silica film 
fills essentially all the craters and cavities of the surface 
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of the ceramic material and is apparently everywhere in 
close contact to the coating, despite of the rough surface 
topography of the Bioverit® II material. This roughness 
also accounts for the fact that the predominant orienta-
tion of the pore channels as described for the glass sub-
strates can only be found when the pores are in direct 
contact to the surface. Farther from the surface, the nano-
porous silica has an irregular pore system.
Stability tests
The stability of nanoporous silica thin films has been 
studied before by ellipsometry porosimetry and X-ray 
photoelectron spectroscopy. It was found that unfunction-
alized films dissolved within hours [30]. We studied the 
stability of our films using XRD and electron microscope 
techniques.
Figure 2 SEM and STEM images of a single nanoporous silica layer on a glass slide substrate. (A) SEM side-view of an intentionally broken 
layer, (B) SEM view on the surface showing open pore mouths of the structure, (C) STEM cross-section of the film revealing the disordered 
interrupted pore channels.
Figure 3 STEM image of a cross-section of the nanoporous silica 
film on Bioverit® II substrates, showing at the bottom the ceramic 
(white) and the disordered nanoporous structure of the coating.
The films were exposed to phosphate buffered saline 
(PBS) with 10% (v/v) fetal calf serum for different times. 
XRD patterns measured on the so obtained samples 
revealed that the nanoporous structure of the film is 
destroyed, showing different successive phases (Figure 4) 
[28]. Within the first 6 h of incubation the intensity of the 
reflection at 1.6° 2θ decreased, but was still visible after 
12  h of exposure time. Concomitantly, the very broad 
reflection at 3° 2θ vanishes and a broad reflection appears 
in the range from 2.0 to 2.5° 2θ. After 24 h, no reflections 
can be discerned anymore.
Interestingly, profilometer measurements and micro-
scopic controls on glass substrates showed that a silica 
film with reduced thickness is still present on the surface 
after at least 24 h of exposure to the medium. In view of 
these results, a sample that showed a reduction of the 
reflection intensity at 1.6° 2θ and the appearance of the 
peak in the range from 2.0 to 2.5° 2θ (corresponding to 
Figure 4, 12 h) was freshly produced and transferred to 
STEM analysis immediately in order to clarify possible 
structural changes of the nanostructure (Figure 5).
STEM images of a cross-section of the film revealed 
that the nanostructure of the film rearranges to a packing 
of small silica nanoparticles with a size of 7–8 nm. The 
uniform size of these nanoparticles and their regular 
packing, which is especially prominent near to the sub-
strate (note the striations in Figure 5) probably causes the 
broad reflection in the range from 2.0 to 2.5° 2θ in the XRD, 
referring to a repeat size of 4.2 nm. The transformation 
between these two phases probably involves the partial 
dissolution of the nanoporous structure and reformation 
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of the silica in the form of nanoparticles, possibly corre-
sponding to an Ostwald ripening-type processes.
The rate of deterioration of nanoporous silica films 
is a function of the composition [30] and of modifica-
tion. Silanization reactions with organic silanes as well as 
binding biomolecules to the coating can protect the film. 
For example, for a coating which was modified by the 
immobilization of alkaline phosphatase using the linker 
3-aminopropyltrimethoxysilane [27], clear reflections 
from the nanopore structure can still be observed up to 
Figure 4 XRD patterns of a nanoporous silica coating on a glass 
slide before (0 h) and after exposure to 0.01 m PBS with 10% (v/v) 
fetal calf serum for different time intervals (12, 18 and 24 h).
Figure 5 STEM image of a cross-section of a single nanoporous 
silica film exposed for 12 h to 0.01 m PBS with 10% (v/v) fetal calf 
serum. After exposure to physiological medium the nanoporous 
structure of the silica film is destroyed. The film rearranges to a 
packing of silica nanoparticles with a size of 7–8 nm.
14 h of incubation. Afterwards, up to a time period of 24 
h, the intensity of the reflection at 1.6° 2θ, which indicates 
the presence of the nanoporous structure, is reduced, but 
the very broad reflection in the range from 2.0 to 2.5° 2θ 
persists. After longer time periods, no diffraction peaks 
can be observed anymore.  Nevertheless, a silica layer is 
still present which may, for example, still contain drug 
molecules to be delivered. Also, it is difficult to compare 
in vitro and in vivo conditions, and the surrounding of 
an implant in the middle ear directly after implantation 
is not well defined. Although the middle ear does not 
contain liquids in a healthy state, blood and iquor may be 
present directly after the operation. It is therefore difficult 
to state whether the deterioration of the nanoporous silica 
layer occurs in a similar way as the in vitro degradation in 
liquids. Despite this, we can show in the following that a 
coated implant is able to release an effective amount of 
ciprofloxacin within the first days after implantation, as 
supported by animal experiment in rabbits [31].
Drug release
Bioverit® II platelets as substrates were coated three 
times using the procedure described in the experimen-
tal section. Part of the samples was modified with sul-
fonic acid groups by first reacting with the silane linker 
3-mercaptotrimethoxysilane and subsequent oxidation 
of the thiol groups with hydrogen peroxide. This chemi-
cal modification creates negatively charged groups on the 
pore surface in order to increase the amount of inserted 
ciprofloxacin molecules, which are positively charged at 
pH 4. This strategy was first derived using glass plates as 
supports, where in vitro studies showed excellent biocom-
patibility in cell culture studies and effective antibacterial 
action in bacterial culture tests [19]. The transfer of this 
strategy to Bioverit® II supports paved the way for in vivo 
studies in infected middle ears of rabbits, using middle 
ear prostheses fabricated from this glass-mica ceramic 
[31, 32].
Both groups of samples (with a nanoporous silica 
coating and with the additional sulfonate modification) as 
well as plain non-coated Bioverit® II were loaded with the 
antibiotic ciprofloxacin and release profiles were recorded 
by UV-vis measurements in 0.01 m phosphate buffered 
saline (PBS). The recorded release profiles are shown in 
Figure 6.
Interestingly, a plain Bioverit® II surface already 
demonstrated a high drug release amount of 4.5 µg cm-2 
of the macroscopic surface, revealing the high drug 
release capacity of the Bioverit® II, which can probably be 
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accounted for by the rough surface texture. With the nan-
oporous coating, only a modest increase up to 5 µg cm-2 
was achieved. The effect of the sulfonic acid modifica-
tion can be clearly seen. The amount released was raised 
nearly twofold up to 9 µg cm-2. This is similar to the case in 
a preceding study with a nanoporous silica layer on glass 
slides [27]. All samples exhibited a burst release behavior, 
indicating that ciprofloxacin could freely diffuse out of 
the pores. This behavior has been shown to be beneficial 
in an animal experiment, namely an infected middle ear 
model in rabbits. An infection with P. aeruginosa bacte-
ria was effectively antagonized by such a ciprofloxacin-
carrying implant coating [31]. This result suggests that 
this type of implant coating is useful to fight middle ear 
infections which either occur at the time of implantation 
or which are chronic.
 Biocompatibility tests: cell tests and gene 
expression profiling
As a representative cell type for bony tissue-implant 
interactions, the murine mesenchymal precursor cell line 
C3H10T1/2 was used to establish a cell culture model. 
Cells were seeded on microscope glass slides, either plane 
ones or ones coated with an unstructured or a nano-
porous silica layer. The material-cell interactions were 
monitored microscopically. To exclude any interference, 
serum was omitted from the cell culture medium during 
the initial cell attachment phase. The cells adhered to 
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Figure 6 Profiles for the release of ciprofloxacin from plain  
Bioverit® II substrates (squares), from Bioverit® II substrates coated 
with a nanoporous silica film (triangles), and from samples with 
a nanoporous coating which had additionally been modified with 
sulfonic acid groups (circles). Release experiments were conducted 
in 0.01 m PBS. The cumulative release is given in mass per cm-2 of 
the macroscopic substrate surface.
both, unstructured as well as nanoporous silica layers, 
with indistinguishable efficiency. Similarly, during sub-
sequent incubation under standard cell culture condi-
tions, the cells spread out on the coated slides and cell 
proliferation was similar as on plain glass and almost as 
high as on cell culture-optimized polystyrene surfaces, 
independent of the absence or presence of the nanostruc-
ture (Figure 7).
In comparison, cells did not adhere to as-synthesized 
nanostructured silica surfaces, indicating that calcina-
tion of the coatings is essential for efficient cell adhesion 
and cell proliferation (data not shown). This finding is 
in accordance with the well-known anti-adhesive prop-
erties of polyethyleneglycol (PEG) moieties, which are 
part of the amphiphilic block copolymer and which is 
removed upon calcination. In conclusion, after calcina-
tion the nano porous silica coating investigated was highly 
 biocompatible and could serve as substrates for various 
anchorage-dependent cell types.
A further cell culture assay was employed to compare 
plain Bioverit® II with a material where a nanoporous 
silica layer was placed on a Bioverit® II support. After 3 h, 
the mesenchymal precursor cells have attached to both 
surfaces in a similar manner but have not yet spread out. 
After 3 days, the cells on plain Bioverit® II have spread 
very strongly. In comparison, the nanoporous silica layer 
is slightly less bioactive, shown for example by the pres-
ence of some round cells. This slight reduction in bioac-
tivity is understandable with regard to the well-known 
very high bioactivity of Bioverit® II which does not put in 
question the good biocompatibility of nanoporous silica.
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Figure 7 Biocompatibility of nanoporous silica coatings with bone 
precursor cells. C3H10T1/2 murine mesenchymal precursor cells 
were seeded on the substrates indicated and incubated under 
standard cell culture conditions for 3 days. For each substrate the 
resulting cell density per cm2 is shown.
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Since cell culture tests cannot predict all in vivo 
implant properties, animal models are essential for 
implant material testing. In particular, mice are an 
extremely well-characterized animal model, allowing 
both in-depth histological as well as detailed molecular 
genetics analyses. For molecular characterization of the 
implant-tissue interactions, a newly established murine 
middle ear model was adapted [33]. Cylindrical Bioverit® 
II implants with length and diameter both of 1 mm were 
coated with nanoporous silica and were inserted into the 
middle ear cavity.
The animals recovered from the surgery without 
complications and appeared healthy. After 2 months the 
petrous bone which enclosed the implant was removed 
and the RNA was extracted (Figure 9). The amount of RNA 
was sufficient and of high quality suitable for gene expres-
sion analysis (Figure 10).
The gene expression profiles obtained from middle 
ears with and without implants were highly related and 
reproducible. Cluster analysis showed that the method 
was reliable and sensitive such that even differences 
between the individual inbred mice could be detected. 
No significant increase in immune response or inflamma-
tory gene expression could be detected in the presence 
of the implants, indicating that the nanoporous silica 
coating was highly biocompatible. These results are in 
accord with previous histological analyses of Bioverit® 
II implants coated with a nanoporous silica layer which 
were conducted in both rabbit and murine animal models 
[33–35]. Since gene array analysis was able to detect an 
inflammatory response in the case of iron implants, the 
method per se is sufficiently sensitive in our hands [36]. 
Overall, these data indicate that both, Bioverit® II implants 
as well as nanoporous coatings, did not cause detectable 
Uncoated Bioverit® II
3 hours
3 days
Unstructured silica
coating
Nanoporous silica
coating
Figure 8 Cell adhesion and cell proliferation on nanoporous silica-coated substrates, eGFP labeled C3H10T1/2 cells, were seeded on plain 
Bioverit® II, Bioverit® II coated with either an unstructured or with a nanoporous silica layer as indicated. Cell adhesion was determined 
3 hours after seeding and cell proliferation after 3 days.
Figure 9 Explanted tissue isolated from mouse middle ears 
2 months after implantation. The cylindrical Bioverit® II implant with 
1 mm in diameter and 1 mm in length is lying between two explanted 
middle ear samples. RNA was extracted from the tissue and used for 
whole genomic gene expression analysis.
inflammatory responses in the middle ear of mice. The dif-
ferences between the data shown in Figure 10, where no 
significant change in gene expression could be found and 
the previously published data, where significant changes 
in response to iron implants were observed, could be 
interpreted that that Bioverit® II implants and the nano-
porous coatings act less inflammatory than iron implants. 
The view that iron acts more inflammatory than clinically 
established implant materials was indeed supported by 
more recent data obtained in our laboratory [37]. Alter-
natively, it cannot be excluded that the middle ear bone 
cavity locally contains inflammatory reactions and pre-
vents them from spreading to nearby tissue layers. Since 
it was not feasible to isolate solely tissue from within the 
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cavity for the gene expression analysis, such an effect 
may have contributed to limit the detected inflammatory 
response.
Materials and methods
Coatings with nanoporous silica
Two different types of base materials were used as substrates for the 
coatings, namely glass (Glasbearbeitung Henneberg & Co., Martin-
roda, Germany) and Bioverit® II (3di GmbH, Jena, Germany). Abso-
lute ethanol was purchased from Merck (Darmstadt, Germany). All 
other chemicals were obtained from Sigma-Aldrich Chemie GmbH 
(Munich, Germany). All chemicals were used without further puri-
fication.
Initial drug release investigations of coated glass substrates 
were conducted on standard glass slides (26 mm × 76 mm × 0.95 mm) 
[19]. Due to better handling and high costs of the  material, Bioverit® 
II substrates with size of half a glass slide (26  mm × 38 mm, height 
1.0–1.3 mm) were used as supports in  further drug release studies. For 
cell culture testing, coated Bioverit® II discs with a  diameter of 9 mm 
and 1.5–2.0  mm height were used as a substrate. For quantitative 
cell culture analyses and stability tests, the dip-coating procedure 
was applied once to standard microscope glass slides. For implanta-
tion into mice, spray-coated Bioverit® II cylinders of 1 mm diameter 
and 1 mm height were used. Prior to the coating, all specimens were 
cleaned in an ultrasonic bath, first in absolute ethanol and then in 
acetone for 10 min each.
Figure 10 Highly similar gene expression patterns in middle ears 
with and without nanoporous silica coated implants. Tissue was 
isolated from mouse middle ears 2 months after implantation of 
cylindrical implant with 1 mm in diameter and 1 mm in length. RNA 
was extracted from the tissue and used for whole genomic gene 
expression analysis. An average link cluster analysis of the gene 
array expression data was done by using the program ‘Cluster’ from 
the Eisen lab (http://rana.lbl.gov/EisenSoftware.htm). The differ-
ences of gene expression profiles is represented in the graph by 
the distances of the vertical bars: The implant materials used were 
as follows: BR, Bioverit® II implant in right ear; CR, Bioverit® II with 
nanoporous silica coating in right ear; PL, corresponding combined 
left ears without implants from all mice with implants in the right 
ear; L, left ear without implant from a mouse without any implants; 
R: corresponding right ear without implant.
The preparation of the nanoporous film has been described 
elsewhere [19, 27, 28]. The solution used for the preparation of na-
nostructured silica coatings contained ethanol, water, hydrochloric 
acid, tetraethoxysilane (TEOS) as a silica source and poly(ethylene 
glycol)-poly(propylene glycol)-block-co-polymer, (Sigma-Aldrich, 
EO20PO70EO20, average Mn≈5800, similar to Pluronic® P-123, BASF) 
as the structure-directing agent [38]. The dip-coating solution had a 
molar composition of TEOS: EtOH : H2O : HCl : EO20PO70EO20 = 1 : 48.9 
: 26.9 : 0.06 : 0.0135. It was prepared by adding TEOS to EO20PO70EO20 
dissolved in a mixture of ethanol, water and hydrochloric acid; the 
solution was stirred for about 10 min before coating the specimens. 
For the preparation of unstructured silica coatings as used for the cell 
culture assay, a similar solution but without the block-co-polymer 
was used. Glass and plain Bioverit® II samples were coated using a 
dip-coating procedure, employing a DC Small Dip-Coater with 75 mm 
travel from NIMA (Coventry, England), operated in a climate box at 
a constant humidity adjusted by 50% (w/w) glucose solution. The 
samples were immersed in the coating solution and then withdrawn 
perpendicular to the surface of the solution with a speed of approxi-
mately 1 mm min-1. The samples were then left at constant humidity 
for 5 min followed by a drying step at 60°C for 30 min. The substrates 
for drug release experiments from coated Bioverit® II substrates were 
coated three times. This threefold coating of Bioverit® II substrates 
is necessary in order to fill the cavities present on the rough surface 
of this biomaterial and to create a continuous layer. For cell culture 
experiments and stability tests the glass substrates were coated once. 
After coating, the specimens were dried at 60°C over night, followed 
by calcination at 415°C for 4 h (rate of heating/cooling 1°C min-1). For 
the investigations in the mouse model the specimens were spray-
coated instead of using the dip-coating techniques. For this purpose, 
the cylinders were laid on the plain side and spray-coated with three 
pumps of a fine disperser followed by a drying step for 30  min at 
60°C. Afterwards the same procedure was performed to the cylinder 
lying on the other plain side. Afterwards the samples were treated as 
described above.
For the drug release studies, the nanoporous silica was modi-
fied with sulfonic acid groups and with further silanization reactions 
to control the release. The corresponding reactions are described in 
detail elsewhere [19, 39]. In brief, sulfonate groups were established 
by binding the silane linker 3-mercaptotrimethoxysilane to the si-
lanol groups of the silica surface and by subsequent oxidation of the 
thiol groups with hydrogen peroxide.
Characterization methods
X-ray diffraction (XRD) analysis of coated glass substrates and Bio-
verit® II disks were recorded on a Stoe (Darmstadt, Germany) θ/θ-
diffractometer in reflection geometry using CuKα radiation and a 
secondary beam monochromator (graphite). XRD analysis of coated 
Bioverit® II cylinders was conducted using a Stoe Stadi P powder dif-
fractometer (Stoe & Cie GmbH, Darmstadt, Germany) in transmission 
geometry and CuKα1 radiation (λ = 1.540 Å). Three Bioverit® II cylin-
ders were inserted in the rotating sample holder.
Scanning transmission electron microscope (STEM) images 
were collected at 200 keV in high-angle annular dark-field (HAADF) 
mode on a field-emission instrument of the type JEM-2100F from 
JEOL Ltd. (Tokyo, Japan). Film on substrate was epoxy-glued against 
a silicon wafer as counterbody and prepared in cross-section by saw-
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ing, polishing, and final thinning by an argon ion-beam to obtain 
electron transparent regions.
UV-vis measurements for the determination of ciprofloxacin 
in 0.01 m PBS were collected on a spectrophotometer UV-mini 1240 
(Shimazu, Duisburg, Germany) at a wavelength of 275 nm.
Drug loading and release procedure
The drug loading and release procedure used have been described 
in detail elsewhere [19]. Insertion of the antibiotic ciprofloxacin into 
the nanoporous structure was carried out in a 60 mm ciprofloxacin 
solution in hydrochloric acid (pH 4). The  release  experiment was 
conducted in a 0.01 m PBS solution. The release measurements were 
conducted as follows. Five samples were placed into 25 ml of a pre-
warmed solution (37°C) of 0.01 m PBS and kept at this temperature. 
The measurements of the ciprofloxacin concentration in the solution 
took place after fixed time intervals of 15, 35, 55, 75, 135, 195 and 315 
min. Afterwards, the measurements were  performed every 24 h. The 
whole medium was replaced after each measurement to simulate dy-
namic fluid conditions in the body.
Stability experiments
In order to investigate the stability of the nanoporous silica film in 
physiological media we exposed glass samples coated once with the 
nanoporous silica film to a 10% (v/v) fetal calf serum in 0.01 m PBS 
solution. The experiments were conducted at 37°C for different time 
intervals from 6 to 24 h mimicking the medium of cell culture experi-
ments. Afterwards, the presence of the nanoporous structure of the 
film was checked by XRD measurements as presented elsewhere [28]. 
A sample which had been exposed to fetal calf serum for 12 h, show-
ing an XRD pattern with an intensity reduced reflection at 1.6° 2θ and 
a novel broad reflection in the range from 2.0 to 2.5° 2θ, pointing to 
a collapse of the nanostructure, was chosen for further investigation 
by STEM in order to elucidate the rearrangement of the film structure.
Cell culture assays
NIH3T3 murine fibroblast cells and C3H10T1/2 murine mesenchymal 
progenitor cells as a bone-related cell line, respectively, were cul-
tured on Bioverit® II (3di, Jena, Germany), glass or nanoporous sil-
ica coated microscope slides as substrates for cell attachment. Cells 
were maintained under standard cell culture conditions in Dulbec-
co’s Modified Eagle Medium (DMEM, Gibco BRL Life Technologies, 
Eggenstein, Germany) with fetal calf serum (FCS; Cytogen,  Berlin, 
 Germany) at 37°C with 5% CO2. The various cell substrates were steri-
lized by incubation in 100% ethanol for 5 min, and then rinsed with 
PBS (pH 7.4). To determine the ability of cells to adhere to nanopo-
rous coatings, cells were seeded at a density of 104 cm-2 and incubat-
ed in DMEM without FCS at 37°C with 5% CO2 for 30 min. Adherent 
cells were photographed using an inverted light microscope (Zeiss, 
Oberkochen, Germany). The cell density was estimated by manually 
counting the cells. Subsequently, 10% (v/v) FCS was added to the cell 
culture medium and the cells were incubated for 3 additional days to 
determine cell proliferation.
To monitor cell-implant interactions, a stably transfected mu-
rine mesenchymal precursor cell line C3H10T1/2 expressing green 
fluorescent protein (eGFP) from the constitutive SV40 promoter (BD 
Bioscience/Clontech) was used. Implant materials were disinfected 
by incubation in ethanol for 24 h prior to use. The material samples 
were transferred to standard tissue culture wells (Costar 24 well cul-
ture cluster, Corning Incorporated, Corning, NY, USA). eGFP-labeled 
C3H10T1/2 cells were then seeded onto the material samples at a den-
sity of 2 × 104 cm-2 and incubated in serum-free DMEM at 37°C in a hu-
midified atmosphere with 5% CO2. Cell adhesion was determined by 
UV-fluorescence microscopy with an excitation light band-pass filter 
of 405–495 nm and a FITC emission filter (535AF45; Omega Optical; 
Optophotonics, Eaubonne, France). To determine cell proliferation, 
fetal calf serum was subsequently added to a final volume of 10% 
of the cell culture medium and the cells were incubated further. Cell 
spreading and cell proliferation were examined after 3 h, 1 day and 
3 days after seeding, respectively.
Implantation procedure
Female BALB/c mice (Harlan Winkelmann GmbH, Borchen,  Germany) 
of 16–22 g body weight each were kept in groups of 1–5 mice in indi-
vidually aerated cages and fed a standard laboratory diet. Surgery was 
done as described previously [33]. Briefly, the animals were anesthe-
tized by intraperitoneal injection of 10 mg kg-1  xylazin (Rompun® 2%, 
Bayer Vital GmbH, Leverkusen, Germany) and 100  mg  kg-1 ketamin 
(Albrecht, Aulendorf, Germany) and 5 mg  kg-1 of carprofen (Rimadyl, 
Pfizer Pharma GmbH, Karlsruhe, Germany).  Surgery of the left ear 
was performed with the aid of a binocular (SV11 stereoscopic zoom 
microscope, Zeiss, Oberkochen, Germany). The tympanic cavity was 
opened with a hypodermic needle and the cylinder inserted as a plug 
in the hole. Bioverit® II cylinders of 1 mm diameter and 1 mm height, 
respectively, with or without the nanoporous silica coating were in-
serted into the middle ear by puncturing the  bulla tympanica of the 
left ear. The implanted Bioverit® II cylinders were in contact with the 
bony structure of the middle ear cavity at undefined locations. After 
2, 6 and 12 weeks, respectively, the petrous bone was removed. The 
wound was closed by using an absorbable suture (Ethicon Vicryl® 
5-0 or 6-0; Johnson+Johnson Intl, Brussels,  Belgium). Antibiotics tri-
methoprim and sulphonamide (0.5% Cotrim-K; Ratio pharm GmbH, 
Ulm, Germany) were supplied in the drinking water for 7 days follow-
ing the surgery. All animal experimentation was performed under the 
permission AZ 33.42502/07 of the local authorities (Bezirksregierung 
Braunschweig, Dezernat 509, Braunschweig).
Gene expression profiling
Mice were decapitated and the petrous bone with a small amount 
of adhering tissue was surgically removed and immediately frozen 
in liquid nitrogen. The frozen samples were crushed with a pestle 
in a ceramic mortar while still in the presence of liquid nitrogen. 
The samples were further processed as previously described [36]. 
Briefly, total RNA was isolated from the frozen powder with a kit 
according to the manufacturer’s instructions (Rneasy Mini Kit, 
Qiagen; Hilden, Germany). RNA was resuspended in water and the 
concentration and purity determined using a NanoDrop ND-1000 
analyser (Peqlab Biotechnologie GmbH, Erlangen, Germany). RNA 
integrity was determined by gel electrophoresis with the Nano As-
say (Agilent 2100 Bioanalyzer, Agilent Technologies; Waldbronn, 
Germany). RNA expression profiling was performed as previously 
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described [40, 41]. Probes for hybridization were synthesized ac-
cording to the manufacturer’s protocol as follows (Affymetrix; San-
ta Clara, CA). From 3 µg of total RNA biotin-labeled  target synthesis 
reactions were performed. Briefly, 3 µg total RNA were converted to 
dsDNA using 100 pmol of a T7T23V primer (Eurogentec; Seraing, 
Belgium) containing T7 promoter sequences. The cDNA was then 
used directly in an in vitro transcription reaction in the presence 
of biotinylated nucleotides. The concentration of biotin-labeled 
cRNA was determined by UV absorbance. 12.5 µg of biotinylated 
cRNA pre paration was fragmented and placed in a hybridization 
cocktail with four biotinylated hybridization control probes (BioB, 
BioC, BioD, and Cre). Samples were hybridized to an identical lot of 
Affymetrix GeneChip MOE430 2.0 for 16 h. After hybridization, the 
chips were washed, stained with SA-PE and read using an Affym-
etrix GeneChip fluidic  station and scanner with Affymetrix standard 
software GCOS 1.2 GeneChip® Operating Software that controls the 
fluidics stations and scanner (Affymetrix; Santa Clara, CA, USA). 
All experiments were scaled to a target intensity of 150 using the 
preset default values of GCOS 1.2. For the significance ranking of 
the GO categories the list of ProbesetIDs with twofold or higher dif-
ferences were analyzed with the program DAVID using a derivative 
of Fisher’s Exact probability test [42]. Clustering analysis was per-
formed using the program Gene Cluster 3.0. For hierarchical aver-
age linkage clustering the  array data was log transformed, genes 
and arrays median centered and then normalized. The associated 
program TreeView was employed to graphically represent the clus-
tering data [43].
Conclusions
This paper presents basic results on nanoporous silica 
coatings with the perspective to use these multifunctional 
layers on implants. For the in-depth characterization of 
these layers glass slides were used as supports, whereas 
for more applied studies, the well-established biomaterial 
Bioverit® II was used.
X-ray diffraction as well as scanning transmission 
electron microscopic studies show that the coatings have 
a disordered pore structure which is however regular 
with regard to the pore diameter. Our data shows that 
the nanoporous silica coatings are highly biocompa tible 
in cell culture assays as well as in vivo in a mouse ear 
model. Therefore, nanoporous silica coatings that could 
be loaded with bioactive compounds appear as a promis-
ing strategy to add functionality to implants. The nano-
structure of the porous coating is only stable up to 12 h 
in physiological media, as is indicated by the disappear-
ance of the characteristic XRD reflections and as was 
observed before [30]; modification of the silica surface 
can prolong that time. After the disappearance of the 
characteristic XRD reflections, an unstructured silica 
layer remains which still shows favorable properties with 
regard to the activity of bound enzymes [27], for drug 
release (as shown here and in ref [19]) and for the deliv-
ery of bioactive molecules as the bone morphogenetic 
protein BMP2 [28]. Cultured cells could attach, spread 
and proliferate efficiently on the nanoporous coating 
(this paper and [34]). In the middle ear cavity of mice, 
Bioverit® II samples with a nanoporous coating did not 
provoke any significant inflammatory reaction as sub-
stantiated here by the modern method of whole genome 
expression profiling. These results, together with data 
from animal experiments using rabbits [subcutaneous 
and in the middle ear [33–35], show that the nanoporous 
silica coating is highly biocompatible. The internal space 
and the increased surface area have shown to be highly 
suitable for applications as a drug reservoir for the 
binding and presenting bioactive substances [19, 27, 28].
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